This Article Full Text Full Text (PDF) An erratum has been published All Versions of this Article: 200309-1287OCv1 169/9/1034    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Phansalkar, A. R. Articles by Hsia, C. C. W. Search for Related Content PubMed PubMed Citation Articles by Phansalkar, A. R. Articles by Hsia, C. C. W.

Nitric Oxide Diffusing Capacity and Alveolar Microvascular Recruitment in Sarcoidosis

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas

Correspondence and requests for reprints should be addressed to Connie C.W. Hsia, M.D., Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390–9034. E-mail: connie.hsia{at}utsouthwestern.edu

We measured diffusing capacities for carbon monoxide (DL_CO) and nitric oxide, lung volume, and cardiac output by a rebreathing technique at two alveolar O₂ tensions (PA_O2) at rest and exercise. Membrane diffusing capacity for CO (DM_CO) and VC were estimated from DL_CO by the Roughton-Forster (RF) method and also from simultaneous lung diffusing capacity for NO and DL_CO measured at one O₂ tension (modified RF method). Estimates by these methods agreed closely in normal subjects (Tamhane et al., Chest 2001;120:1850–1856). Using these methods, we studied patients with stages II–III pulmonary sarcoidosis to determine (1) whether the modified RF method accurately estimates DM_CO and VC in parenchymal disease and (2) whether sarcoidosis alters recruitment of diffusing capacity with respect to cardiac output. In patients, DM_CO and VC estimated by the two methods agreed closely. DM_CO was disproportionately reduced relative to VC at any given cardiac output, and the slope of the relationship between DL_CO and cardiac output was moderately, though significantly, below normal. We conclude that in sarcoidosis (1) the modified RF method provides comparable estimates of DM_CO and VC as the standard RF method and (2) the limitation to diffusive gas transport resides primarily in the membrane barrier, although recruitment of microvascular reserves is also modestly impaired.

Key Words: membrane diffusing capacity • nitric oxide • capillary blood volume • exercise • Roughton-Forster relationship

This article has been cited by other articles:

				C. C. W. Hsia, P. D. Wagner, D. M. Dane, H. E. Wagner, and R. L. Johnson Jr. Predicting diffusive alveolar oxygen transfer from carbon monoxide-diffusing capacity in exercising foxhounds J Appl Physiol, November 1, 2008; 105(5): 1441 - 1447. [Abstract] [Full Text] [PDF]

				W. W. Chance, C. Rhee, C. Yilmaz, D. M. Dane, M. L. Pruneda, P. Raskin, and C. C.W. Hsia Diminished Alveolar Microvascular Reserves in Type 2 Diabetes Reflect Systemic Microangiopathy Diabetes Care, August 1, 2008; 31(8): 1596 - 1601. [Abstract] [Full Text] [PDF]

				C. Yilmaz, D. M. Dane, and C. C. W. Hsia Assessing recruitment of lung diffusing capacity in exercising guinea pigs with a rebreathing technique J Appl Physiol, July 1, 2008; 105(1): 316 - 321. [Abstract] [Full Text] [PDF]

				C. Borland A place for TL,NO with TL,CO? Eur. Respir. J., May 1, 2008; 31(5): 918 - 919. [Full Text] [PDF]

				H. Dressel, L. Filser, R. Fischer, D. de la Motte, W. Steinhaeusser, R. M. Huber, D. Nowak, and R. A. Jorres Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide: Dependence on Breath-Hold Time Chest, May 1, 2008; 133(5): 1149 - 1154. [Abstract] [Full Text] [PDF]

				S. N. Glenet, C. De Bisschop, F. Vargas, and H. J. P. Guenard Deciphering the nitric oxide to carbon monoxide lung transfer ratio: physiological implications J. Physiol., July 15, 2007; 582(2): 767 - 775. [Abstract] [Full Text] [PDF]

				G. S. Zavorsky and J. M. Murias A small amount of inhaled nitric oxide does not increase lung diffusing capacity Eur. Respir. J., June 1, 2006; 27(6): 1251 - 1257. [Abstract] [Full Text] [PDF]

				I. van der Lee, P. Zanen, J. C. Grutters, R. J. Snijder, and J. M.M. van den Bosch Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest, February 1, 2006; 129(2): 378 - 383. [Abstract] [Full Text] [PDF]

				T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 675 - 685. [Full Text] [PDF]

				I. van der Lee, P. Zanen, and G. S. Zavorsky Diffusion Capacity for Nitric Oxide and Carbon Monoxide Chest, November 1, 2004; 126(5): 1708 - 1710. [Full Text] [PDF]

				E. Abraham ERRATA: Nitric Oxide Diffusing Capacity Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 921 - 921. [Full Text] [PDF]